STAAR Surgical Company
General ticker "STAA" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.1B (TTM average)
STAAR Surgical Company follows the US Stock Market performance with the rate: 19.2%.
Estimated limits based on current volatility of 3.0%: low 22.79$, high 24.20$
Factors to consider:
- Earnings expected soon, date: 2026-08-12 amc
- Total employees count: 957 (-21.0%) as of 2026
- US accounted for 6.3% of revenue in the fiscal year ended 2024-12-27
- Top business risk factors: Operational and conduct risks, Market competition, Distributor dependency, Trade tariffs, Currency fluctuations
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-02 to 2028-01-02
- 2026-01-02 to 2027-01-02 estimated range: [19.84$, 34.05$]
- 2027-01-02 to 2028-01-02 estimated range: [19.73$, 33.81$]
Financial Metrics affecting the STAA estimates:
- Negative: with PPE of -71.1 at the end of fiscal year the price was high
- Negative: Operating cash flow per share per price, % of -2.94 <= 0.30
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 3.99 > -0.65
- Positive: Shareholder equity ratio, % of 76.20 > 63.79
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: -9.07 < Industry operating profit margin (median), % of -7.44
Short-term STAA quotes
Long-term STAA plot with estimates
Financial data
| YTD | 2023-12-29 | 2024-12-27 | 2026-01-02 |
|---|---|---|---|
| Operating Revenue | $322.42MM | $313.90MM | $239.44MM |
| Operating Expenses | $294.32MM | $326.51MM | $331.15MM |
| Operating Income | $28.10MM | $-12.61MM | $-91.71MM |
| Non-Operating Income | $5.60MM | $3.56MM | $9.45MM |
| R&D Expense | $44.40MM | $53.97MM | $40.05MM |
| Income(Loss) | $33.70MM | $-9.05MM | $-82.26MM |
| Taxes | $12.35MM | $11.16MM | $-1.81MM |
| Net Income(Loss)* | $21.35MM | $-20.21MM | $-80.45MM |
| Stockholders Equity | $385.95MM | $397.33MM | $344.18MM |
| Inventory | $35.13MM | $43.30MM | $55.50MM |
| Assets | $488.69MM | $509.52MM | $451.68MM |
| Operating Cash Flow | $14.59MM | $15.72MM | $-34.23MM |
| Capital expenditure | $18.19MM | $23.39MM | $5.82MM |
| Investing Cash Flow | $74.35MM | $-59.22MM | $46.34MM |
| Financing Cash Flow | $7.42MM | $5.72MM | $-4.55MM |
| Earnings Per Share** | $0.44 | $-0.41 | $-1.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.